CONMED Corporation
$39.68
▼
-2.08%
2026-04-21 06:08:00
www.conmed.com
NYQ: CNMD
Explore CONMED Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.2 B
Current Price
$39.68
52W High / Low
$61.08 / $33.21
Stock P/E
25.61
Book Value
$33.36
Dividend Yield
2.05%
ROCE
5.1%
ROE
4.71%
Face Value
—
EPS
$1.51
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
3,900
Beta
0.99
Debt / Equity
85.91
Current Ratio
2.14
Quick Ratio
1.01
Forward P/E
7.46
Price / Sales
0.82
Enterprise Value
$1.98 B
EV / EBITDA
9.82
EV / Revenue
1.44
Rating
None
Target Price
$44.2
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
| 2. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
| 3. | Nuwellis, Inc. | $1.16 | — | $2.85 M | — | -359.88% | -3.83% | $45.42 / $0.96 | $1.56 |
| 4. | Vivos Therapeutics, Inc. | $1.01 | — | $13.14 M | — | -108.39% | -3.35% | $7.95 / $0.96 | $0.31 |
| 5. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
| 6. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 7. | TELA Bio, Inc. | $0.63 | — | $30.55 M | — | -53.21% | -2.23% | $2.2 / $0.5 | $0.14 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 373.2 M | 337.93 M | 342.35 M | 321.26 M | 345.94 M |
| Operating Profit | 36.62 M | 11.88 M | 38.16 M | 15.96 M | 52.5 M |
| Net Profit | 16.74 M | 2.86 M | 21.42 M | 6.04 M | 33.76 M |
| EPS in Rs | 0.56 | 0.09 | 0.71 | 0.2 | 1.12 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.37 B | 1.31 B | 1.24 B | 1.05 B |
| Operating Profit | 102.62 M | 200.33 M | 120.6 M | 70.05 M |
| Net Profit | 47.05 M | 132.42 M | 64.46 M | -80.58 M |
| EPS in Rs | 1.56 | 4.39 | 2.14 | -2.67 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.33 B | 2.31 B | 2.3 B | 2.3 B |
| Total Liabilities | 1.29 B | 1.34 B | 1.47 B | 1.55 B |
| Equity | 1.03 B | 962.68 M | 834.22 M | 745.54 M |
| Current Assets | 672.86 M | 640.01 M | 615.65 M | 581.23 M |
| Current Liabilities | 315.04 M | 278.13 M | 310.73 M | 296.55 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 170.69 M | 166.97 M | 125.35 M | 33.37 M |
| Investing CF | -20.96 M | -13.08 M | -20.03 M | -249.53 M |
| Financing CF | -135.82 M | -151 M | -110.43 M | 225 M |
| Free CF | 150.88 M | 153.88 M | 106.32 M | 11.58 M |
| Capex | -19.81 M | -13.08 M | -19.03 M | -21.79 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 5% | 19.06% | — | — |
| Earnings Growth % | 105.44% | 179.99% | — | — |
| Profit Margin % | 10.13% | 5.18% | -7.71% | — |
| Operating Margin % | 15.33% | 9.69% | 6.7% | — |
| Gross Margin % | 56.08% | 54.33% | 54.64% | — |
| EBITDA Margin % | 20.82% | 15.46% | 2.64% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-09-15 | $0.2 |
| 2025-06-13 | $0.2 |
| 2025-03-14 | $0.2 |
| 2024-12-20 | $0.2 |
| 2024-09-16 | $0.2 |
Stock Splits
No stock split history available.